Cellulite treatment is a cash-pay elective treatment, and how it is described shapes who books and what they expect. This guide is for practice owners, patient coordinators and front desk teams: what federal health sources say about cellulite and about cellulite devices, which claims to avoid, and how to turn requests into well-informed consultations.
- SearchAn adult looks for care near them.
- Your pageWhat you treat, who sees them, one way to book.
- Call or formThey call or send a request.
- Front deskBooks the visit and never guesses a cause.
- Clinical teamThe clinician decides the plan.
1. Know what cellulite treatment is and is not
The National Library of Medicine’s MedlinePlus page on cellulite says “Cellulite deposits cause the skin to look dimpled.” In short:
- “Cellulite is not harmful to your health.”;
- “Many people seek treatment for cellulite because they are bothered by how it looks.”;
- “Be sure you understand the risks and benefits of any treatment for cellulite.”
FDA’s non-invasive body contouring page says “Many of the procedures result in temporary improvement in the appearance of the bulge or cellulite.” As one example device, FDA’s 510(k) record K231092 clears the T-SHAPE 2 for indications including “temporary reduction in the appearance of cellulite”. Record K221336 clears Avéli, used through a small incision, for “long-term reduction in the appearance of cellulite in the buttocks and thigh areas of adult females”, backed by clinical data through one year.
Neither clearance says cellulite is removed, and “long-term” there rests on one year of data, so never claim permanent removal. If your clearance says temporary, say temporary, and advertise only the uses and areas it names (see FDA approved or FDA cleared?).
Keep related services separate. FDA groups procedures “meant to only improve the appearance of cellulite” with non-invasive body contouring, which “will not result in weight loss”, so never sell cellulite treatment as weight loss or fat removal. See how to get more body contouring patients and how to get more liposuction patients.
2. Keep claims in line with the risk information
FDA lists complications reported for all body contouring devices:
- pain or discomfort;
- redness and swelling;
- bruising;
- nodules, lumps that can be felt but not seen.
It adds that “some complications may last a long time, become permanent, or require surgery to correct.” The 510(k) summary for Avéli reports adverse events from its clinical study, including bruising, pain, numbness, seroma, hematoma and “skin indentation (also described as a depression or other irregularity)”. These are that device’s study findings only, not a list for every treatment.
FDA’s aesthetic devices page adds that “a procedure may not always give you the results you want, the effects may be temporary”. So avoid “permanent”, “cellulite gone for good”, “risk-free”, “no downtime”, “painless” and “lose weight”. Better: “a treatment that may temporarily improve the look of cellulite” and “your provider will discuss realistic results with you”.
3. Answer first-call questions honestly
- How much does it cost? Give a clear starting price, say what it includes (the treatment, the provider’s assessment, follow-up visits) and that a series or combining it with other treatments affects the total.
- Is it permanent? “We do not promise permanent results. For many treatments, results are temporary. The provider will explain what to expect at the consultation.”
- Is it safe? “Every cellulite treatment has risks, such as pain, bruising and swelling. The provider will go through them with you at the consultation.”
- Who does the treatment? Give the provider’s name and real credentials. Let callers check them with the state licensing board.
Leave screening to the clinician. Your intake form can ask about areas of concern, past body treatments, implants or metal in the body, and medicines; the clinician decides whether someone is a candidate, which treatment and when. Front desk staff only collect the answers. Use the new patient phone script for the rest of the call, and book the consultation, not the treatment, while the caller is on the line.
4. Plan the consultation and recovery
FDA tells patients to ask “how many treatments will be needed, how long the effects are expected to last, and whether additional procedures will be needed to maintain the effect.” With no standard timeline, ask your clinicians for written notes on each treatment: visit length, how long bruising or swelling may last, when patients can return to work and exercise, and how many sessions and maintenance visits they recommend. Share them with callers early. If you sell a series as a package, see memberships and packages.
Aftercare depends on the treatment; the clinician gives exact instructions.
5. Price, finance and follow up
- Self-pay patients may be entitled to a good faith estimate; see the good faith estimate guide.
- If you advertise a discount, follow advertising prices and specials. Avoid deadline pressure on a treatment decision.
- If you offer financing, follow the patient financing guide.
- Before-and-after photos need written authorization and honest comparisons; see before-and-after photos. FTC guides treat a patient’s result as typical unless you disclose what patients can generally expect.
- Follow up after the consultation without pressure; see consultation to treatment. Track cellulite treatment requests separately, from request to consultation to first treatment.
Where MediLeadGen fits
MediLeadGen sends practices requests from people interested in cash-pay elective treatments. Each request goes to one practice only, with the person’s consent naming that practice, at a fixed price per delivered request.
See how it works for practices
Questions practices ask
How do we get more cellulite treatment patients?
Answer requests quickly, give clear prices and what they include, introduce the provider by real credentials, describe the treatment only as your device’s clearance does, and book a consultation where the clinician can assess the patient and discuss realistic results.
Can we call our cellulite device FDA-approved?
Not unless its own FDA record says so. The example devices in this guide were cleared through a 510(k), not approved. Describe your device only by its clearance and labeling.
Can we promise permanent cellulite removal?
No. FDA says many of these procedures give a temporary improvement in the appearance of cellulite, and the example clearances describe a reduction in appearance, not removal. Do not claim permanent results or weight loss.
What should we tell callers about recovery?
That it depends on the treatment, that they should ask how many treatments they may need and how long the effects are expected to last, and that the clinician gives exact aftercare instructions.
General information for practice teams, not legal or clinical advice. Check device labeling, FDA requirements, state rules and your advertising with counsel and your clinicians. Last reviewed October 2026.